US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist

2.1350
+0.0450+2.15%

Close May 13 16:00 ET

10.65MMarket Cap-711P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-8.27%743K

-21.32%155K

-3.92%196K

-4.39%196K

-5.04%810K

-3.43%197K

-18.73%204K

-18.40%204K

38.51%205K

Operating revenue

-8.27%743K

-21.32%155K

-3.92%196K

-4.39%196K

-5.04%810K

-3.43%197K

-18.73%204K

-18.40%204K

38.51%205K

Cost of revenue

Gross profit

Operating expense

-18.05%8.94M

-39.36%1.99M

-25.78%2.06M

-12.93%1.98M

12.93%2.91M

-20.37%10.91M

-22.50%3.28M

-26.16%2.78M

-32.78%2.27M

11.04%2.58M

Selling and administrative expenses

-5.98%2.96M

-12.59%722K

2.83%762K

-24.09%624K

12.33%847K

-18.26%3.14M

-26.97%826K

-9.85%741K

-6.16%822K

-25.79%754K

-General and administrative expense

-5.98%2.96M

-12.59%722K

2.83%762K

-24.09%624K

12.33%847K

-18.26%3.14M

-26.97%826K

-9.85%741K

-6.16%822K

-25.79%754K

Research and development costs

-22.93%5.98M

-48.37%1.27M

-36.20%1.3M

-6.61%1.36M

13.18%2.06M

-21.19%7.76M

-20.86%2.45M

-30.72%2.04M

-42.08%1.45M

39.75%1.82M

Operating profit

18.83%-8.2M

40.51%-1.83M

27.52%-1.87M

13.82%-1.78M

-14.43%-2.71M

21.38%-10.1M

23.46%-3.08M

26.70%-2.57M

33.93%-2.07M

-9.17%-2.37M

Net non-operating interest income expense

138.83%492K

-67.44%113K

134.09%103K

194.21%114K

353.13%162K

3,333.33%206K

211.58%347K

-60.00%44K

-40.70%-121K

-121.84%-64K

Non-operating interest income

127.93%506K

----

825.00%222K

----

Total other finance cost

-12.50%14K

414.40%393K

-134.09%-103K

-194.21%-114K

-353.13%-162K

-11.11%16K

-137.31%-125K

60.00%-44K

40.70%121K

121.84%64K

Other net income (expense)

124.38%69K

-228.05%-283K

Gain on sale of security

124.38%69K

----

-228.05%-283K

----

Income before tax

24.96%-7.63M

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

19.36%-10.17M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

Income tax

Net income

24.96%-7.63M

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

19.36%-10.17M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

Net income continuous Operations

24.96%-7.63M

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

19.36%-10.17M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

Minority interest income

Net income attributable to the parent company

24.96%-7.63M

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

19.36%-10.17M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

24.96%-7.63M

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

33.09%-10.17M

54.99%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

Basic earnings per share

0.00%-3

-1.5166

66.88%-0.4302

49.83%-0.4042

27.51%-0.6489

66.67%-3

56.70%-1.2991

56.11%-0.8058

23.11%-0.8951

Diluted earnings per share

0.00%-3

-1.5166

66.88%-0.4302

49.83%-0.4042

27.51%-0.6489

66.67%-3

56.70%-1.2991

56.11%-0.8058

23.11%-0.8951

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-8.27%743K	-21.32%155K	-3.92%196K	-3.92%196K	-4.39%196K	-5.04%810K	-3.43%197K	-18.73%204K	-18.40%204K	38.51%205K
Operating revenue	-8.27%743K	-21.32%155K	-3.92%196K	-3.92%196K	-4.39%196K	-5.04%810K	-3.43%197K	-18.73%204K	-18.40%204K	38.51%205K
Cost of revenue
Gross profit
Operating expense	-18.05%8.94M	-39.36%1.99M	-25.78%2.06M	-12.93%1.98M	12.93%2.91M	-20.37%10.91M	-22.50%3.28M	-26.16%2.78M	-32.78%2.27M	11.04%2.58M
Selling and administrative expenses	-5.98%2.96M	-12.59%722K	2.83%762K	-24.09%624K	12.33%847K	-18.26%3.14M	-26.97%826K	-9.85%741K	-6.16%822K	-25.79%754K
-General and administrative expense	-5.98%2.96M	-12.59%722K	2.83%762K	-24.09%624K	12.33%847K	-18.26%3.14M	-26.97%826K	-9.85%741K	-6.16%822K	-25.79%754K
Research and development costs	-22.93%5.98M	-48.37%1.27M	-36.20%1.3M	-6.61%1.36M	13.18%2.06M	-21.19%7.76M	-20.86%2.45M	-30.72%2.04M	-42.08%1.45M	39.75%1.82M
Operating profit	18.83%-8.2M	40.51%-1.83M	27.52%-1.87M	13.82%-1.78M	-14.43%-2.71M	21.38%-10.1M	23.46%-3.08M	26.70%-2.57M	33.93%-2.07M	-9.17%-2.37M
Net non-operating interest income expense	138.83%492K	-67.44%113K	134.09%103K	194.21%114K	353.13%162K	3,333.33%206K	211.58%347K	-60.00%44K	-40.70%-121K	-121.84%-64K
Non-operating interest income	127.93%506K	----	----	----	----	825.00%222K	----	----	----	----
Total other finance cost	-12.50%14K	414.40%393K	-134.09%-103K	-194.21%-114K	-353.13%-162K	-11.11%16K	-137.31%-125K	60.00%-44K	40.70%121K	121.84%64K
Other net income (expense)	124.38%69K					-228.05%-283K
Gain on sale of security	124.38%69K	----	----	----	----	-228.05%-283K	----	----	----	----
Income before tax	24.96%-7.63M	45.28%-1.65M	30.33%-1.76M	23.78%-1.67M	-4.77%-2.55M	19.36%-10.17M	26.69%-3.02M	25.62%-2.53M	31.94%-2.19M	-29.61%-2.43M
Income tax	0					0
Net income	24.96%-7.63M	45.28%-1.65M	30.33%-1.76M	23.78%-1.67M	-4.77%-2.55M	19.36%-10.17M	26.69%-3.02M	25.62%-2.53M	31.94%-2.19M	-29.61%-2.43M
Net income continuous Operations	24.96%-7.63M	45.28%-1.65M	30.33%-1.76M	23.78%-1.67M	-4.77%-2.55M	19.36%-10.17M	26.69%-3.02M	25.62%-2.53M	31.94%-2.19M	-29.61%-2.43M
Minority interest income
Net income attributable to the parent company	24.96%-7.63M	45.28%-1.65M	30.33%-1.76M	23.78%-1.67M	-4.77%-2.55M	19.36%-10.17M	26.69%-3.02M	25.62%-2.53M	31.94%-2.19M	-29.61%-2.43M
Preferred stock dividends
Other preferred stock dividends	0					0
Net income attributable to common stockholders	24.96%-7.63M	45.28%-1.65M	30.33%-1.76M	23.78%-1.67M	-4.77%-2.55M	33.09%-10.17M	54.99%-3.02M	25.62%-2.53M	31.94%-2.19M	-29.61%-2.43M
Basic earnings per share	0.00%-3	-1.5166	66.88%-0.4302	49.83%-0.4042	27.51%-0.6489	66.67%-3	0	56.70%-1.2991	56.11%-0.8058	23.11%-0.8951
Diluted earnings per share	0.00%-3	-1.5166	66.88%-0.4302	49.83%-0.4042	27.51%-0.6489	66.67%-3	0	56.70%-1.2991	56.11%-0.8058	23.11%-0.8951
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall